Prevention and screening

English

Self-care: an important and cost-effective investment

The elevated cost of diabetes can be seen as the result of all previous failures of treatment. As illustrated in this article, treating diabetes complications is far more expensive than taking preventative measures. Future cost cutting, therefore, can only be achieved by improving the level of care, especially in the field of self-management. People with diabetes must be given the means to do this, which can only be attained by future investment.

The EASD 37th annual meeting in Glasgow

The 37th Annual Meeting of the European Association for the Study of Diabetes (EASD) from 9-13 September, hosted by Diabetes UK, was the biggest meeting of the EASD to date. Ten thousand people in total attended the array of satellite symposia, lectures, poster sessions and the exhibition. However, the news of the terrorist attack in New York, shocking to everyone, dampened proceedings and caused logistical chaos for the American delegation. Following is a brief overview of some of the many interesting topics presented at the meeting.

Gestational diabetes: what every mother needs to know

Gestational diabetes is diabetes which is diagnosed when a woman is pregnant. It may have been there before pregnancy without her knowing it, or it may have been brought about by the pregnancy itself. Either way, the woman needs to be as well informed about it as possible, as it can affect both her baby and herself on the short and long term.

Is type 2 diabetes preventable? What the evidence-based guidelines say

Diabetes is the commonest non-communicable disease worldwide. Researchers predict it will increase by around 160% by the year 2025. Sadly, most of this increase will occur in developing countries, which have the least resources to deal with the problem. Even in the most developed countries, health systems are struggling to meet demands for services. In recent years, this has led to a strong focus on prevention research.

Cost-effective approaches to diabetes care and prevention

Diabetes is one of the most costly diseases ever in both human and economic terms. To reduce today's burden and that on future generations, it is in everyone's interest that cost-effective measures to prevent diabetes are identified and implemented. The International Diabetes Federation (IDF) Task Force on Diabetes Health Economics has just completed a review of the evidence on cost-effective approaches to diabetes care and prevention. The timely publication shows that investment in diabetes care can be a cost-effective use of scarce resources. This article provides a brief summary.

Can we prevent diabetes?

President's editorial

Pre-pregnancy care

In women with diabetes who come late in their pregnancy for antenatal care, it is difficult to calculate how many weeks pregnant they are, and hence difficult to optimize the time of delivery. Serious complications of diabetes can deteriorate and there is a high incidence of major birth defects in the babies. These abnormalities arise in the first ten weeks of pregnancy, which may be before a woman even knows she is pregnant or before she would come for antenatal care.

The challenge to movers and shakers: broad strategies to prevent obesity and diabetes

We know that in both Western and Asian adults in the vulnerable overweight groups with impaired glucose tolerance, modest weight loss with specific changes in diet and physical activity can reduce the likelihood of developing Type 2 diabetes. Marked weight loss in severely obese people with diabetes can also ameliorate the risks from their diabetes perhaps for a decade or more. However, clinical interventions to achieve this require intensive personal supervision, which,

A threat to ethnic communities: diabetes and heart disease

The Centers for Disease Control and Prevention (CDC) in the USA has labelled diabetes 'the epidemic of our time'. Indeed, diabetes is the sixth leading cause of death by disease in the USA, with 75% of diabetes-related deaths attributable to cardiovascular disease. According to the US Office of Minority Health, the prevalence of diabetes among African-Americans is about 70% higher than in Caucasians, and the prevalence in Hispanics is nearly double that of Caucasians. Currently it is estimated that 2.3 million African-Americans and 1.2 million Hispanics have Type 2 diabetes in the USA alone.

Diabetes: its indirect costs. The costs of lost production

When someone is sick, be it short-term or long-term, we immediately think of the costs this person has to bear in terms of both physical pain and of the money needed to buy drugs and other supplies to get better or keep the condition under control. We might also go as far as to consider the financial costs borne by national healthcare systems. But there is more to health economics that this. Delve into this article to find out why we cannot remain blind to the so-called indirect costs of diabetes.

Pages